F2 MG Ltd - 28 Jul 2022 Form 3 Insider Report for Allovir, Inc. (KLRS)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
05 Aug 2022, 16:15:43 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
F2 MG LTD., By: Globeways Holdings Ltd., Its: Manager, By: /s/ Morana Jovan-Embiricos, Director

Key filing fact

F2 MG Ltd filed Form 3 for Allovir, Inc. (KLRS) on 05 Aug 2022.

Key facts

  • This page summarizes F2 MG Ltd's Form 3 filing for Allovir, Inc. (KLRS).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2022, 16:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALVR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,059,884
Date
28 Jul 2022
Ownership
Direct
Footnotes
F1
ALVR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
668,072
Date
28 Jul 2022
Ownership
By F2-TPO Investments, LLC
Footnotes
F2
ALVR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,038,583
Date
28 Jul 2022
Ownership
By F2 MC, LLC
Footnotes
F3
ALVR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,193,874
Date
28 Jul 2022
Ownership
By F2 Capital I 2020 LLC
Footnotes
F4
ALVR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
867,678
Date
28 Jul 2022
Ownership
By F2 Bioscience AV 2022 LLC
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares held by F2 MG Ltd. ("F2 MG"). Globeways Holdings Ltd. is the appointed manager of F2 MG and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. Morana Jovan-Embiricos is the founding director of Globeways Holdings Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F2

Shares held by F2-TPO Investments, LLC ("F2-TPO"). Globeways Holdings II Ltd. is the appointed manager of F2-TPO and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F3

Shares held by F2 MC, LLC ("F2 MC"). Globeways Holdings II Ltd. is the appointed manager of F2 MC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F4

Shares held by F2 Capital I 2020 LLC ("F2 2020"). Globeways Holdings II Ltd. is the appointed manager of F2 2020 and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2020. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F5

Shares held by F2 Bioscience AV 2022 LLC ("F2 2022"). Globeways Holdings II Ltd. is the appointed manager of F2 2022 has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2022. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC remarks

Morana Jovan-Embiricos, the founding director of each of Globeways Holdings Ltd. and Globeways Holdings II Ltd., serves on the board of directors of the Issuer. By virtue of her representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Dr. Embiricos has filed separate Section 16 reports disclosing securities of the Issuer that she may be deemed to beneficially own for Section 16 purposes. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .